Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. ...
Lite Strategy, Inc. (NASDAQ: LITS), formerly known as MEI Pharma, Inc., is a unique entity that has transitioned from a clinical-stage pharmaceutical firm to a Litecoin treasury company. The company was incorporated in 2000 and is headquartered in San Diego, California. Initially focused on developing innovative cancer therapies, the company ...Lite Strategy, Inc. (NASDAQ: LITS), formerly known as MEI Pharma, Inc., is a unique entity that has transitioned from a clinical-stage pharmaceutical firm to a Litecoin treasury company. The company was incorporated in 2000 and is headquartered in San Diego, California. Initially focused on developing innovative cancer therapies, the company rebranded in September 2025 to align its business model with cryptocurrency treasury management, specifically accumulating and managing Litecoin (LTC) as its primary reserve asset. This strategic pivot positions LITS as the largest public equity vehicle for Litecoin exposure, targeting investors who want to gain exposure to Litecoin's upside without directly holding the cryptocurrency. The company's leadership includes CEO and CFO Justin (Jay) File, with notable figures such as Charlie Lee, the creator of Litecoin, serving as a Non-Executive Director, and Joshua Riezman as Chief Legal and Strategy Officer. Financially, LITS has minimal revenue from its pharmaceutical operations, with a market cap around $31 million as of early 2026. The company holds significant Litecoin reserves, though it has negative operating cash flow and has incurred losses, with a price-to-book ratio of 0.108 and a negative earnings yield. The company has a small team of only 4 full-time employees, reflecting a lean operation focused on treasury management and strategic investments. Despite its small size, LITS aims to provide a regulated, publicly traded vehicle for Litecoin exposure, leveraging its Nasdaq listing and corporate governance to attract institutional and retail investors. The company's long-term success hinges on Litecoin's price appreciation and its ability to effectively manage its treasury. With a beta of 0.035, the stock price shows low volatility compared to the market, but the company's financials remain in a developmental stage. As of mid-2026, LITS continues to report its Litecoin holdings and financial results, with aspirations to become a leading player in the digital asset treasury space.
EPS estimate unavailable · Fiscal period ending 2026-06-30
D-21
5Y Trend (Revenue, Earnings, FCF)
Metric
Latest
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$0
-100.0%
—
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-15.9M
-189.7%
+23.1%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
—
—
—
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
—
—
—
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
—
—
—
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-20.8M
+58.7%
+21.2%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
—
—
—
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
0.0%
—
—
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
13.50x
+176.8%
+14.8%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
